7 minute read
Antibody-Drug Conjugates (ADCs): Concepts and Challenges
July 5, 2024
As a Senior Scientist of the Cancer Pharm team, Aaron Hua leads the development of syngeneic, CDX, and imaging platforms. He obtained his PhD in immunology from Jilin University (China) and received postdoctoral training in cancer immunology at The Jackson Laboratory (USA). He Joined in Crown Bioscience in 2020 and has collaborated with many well-known pharmaceutical companies, such as Johnson & Johnson (J&J) Global, Abbvie, and Beigene, to help them complete over 100 in vivo anti-tumor efficacy evaluation projects. He has over 20 publications and abstracts.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy
2024-05-23
2022-12-16